These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 8101697

  • 1. Neurotensin and oxyntomodulin-(30-37) potentiate PYY regulation of gastric acid and somatostatin secretions.
    Bado A, Cloarec D, Moizo L, Laigneau JP, Bataille D, Lewin MJ.
    Am J Physiol; 1993 Jul; 265(1 Pt 1):G113-7. PubMed ID: 8101697
    [Abstract] [Full Text] [Related]

  • 2. Oxyntomodulin (glucagon-37) and its C-terminal octapeptide inhibit gastric acid secretion.
    Jarrousse C, Audousset-Puech MP, Dubrasquet M, Niel H, Martinez J, Bataille D.
    FEBS Lett; 1985 Aug 19; 188(1):81-4. PubMed ID: 4018272
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of gastric acid secretion by oxyntomodulin and its 19-37 fragment in the conscious rat.
    Jarrousse C, Carles-Bonnet C, Niel H, Sabatier R, Audousset-Puech MP, Blache P, Kervran A, Martinez J, Bataille D.
    Am J Physiol; 1993 May 19; 264(5 Pt 1):G816-23. PubMed ID: 8498507
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Oxyntomodulin and its C-terminal octapeptide inhibit liquid meal-stimulated acid secretion.
    Jarrousse C, Niel H, Audousset-Puech MP, Martinez J, Bataille D.
    Peptides; 1986 May 19; 7 Suppl 1():253-6. PubMed ID: 3748850
    [Abstract] [Full Text] [Related]

  • 6. Candidate canine enterogastrones: acid inhibition before and after vagotomy.
    Lloyd KC, Amirmoazzami S, Friedik F, Heynio A, Solomon TE, Walsh JH.
    Am J Physiol; 1997 May 19; 272(5 Pt 1):G1236-42. PubMed ID: 9176235
    [Abstract] [Full Text] [Related]

  • 7. Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line.
    Gros L, Thorens B, Bataille D, Kervran A.
    Endocrinology; 1993 Aug 19; 133(2):631-8. PubMed ID: 8102095
    [Abstract] [Full Text] [Related]

  • 8. Effect of peptide YY on gastric acid secretion, gastrin and somatostatin release in the rat.
    Eissele R, Koop H, Arnold R.
    Z Gastroenterol; 1990 Mar 19; 28(3):129-31. PubMed ID: 1971469
    [Abstract] [Full Text] [Related]

  • 9. Effect of peptide YY on cephalic, gastric, and intestinal phases of gastric acid secretion and on the release of gastrointestinal hormones.
    Guo YS, Singh P, Gomez G, Greeley GH, Thompson JC.
    Gastroenterology; 1987 May 19; 92(5 Pt 1):1202-8. PubMed ID: 3557015
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of human gastric acid secretion by peptide YY and secretin.
    Olsen O, Christiansen J.
    Digestion; 1990 May 19; 47(3):156-9. PubMed ID: 2083801
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory effect of the C-terminal octapeptide of oxyntomodulin on pentagastrin-stimulated gastric acid secretion in man.
    Veyrac M, Ribard D, Daures JP, Mion H, Lequellec A, Martinez J, Bataille D, Michel H.
    Scand J Gastroenterol; 1989 Dec 19; 24(10):1238-42. PubMed ID: 2690315
    [Abstract] [Full Text] [Related]

  • 12. Activity of oxyntomodulin on gastric acid secretion induced by histamine or a meal in the rat.
    Jarrousse C, Carles-Bonnet C, Niel H, Bataille D.
    Peptides; 1994 Dec 19; 15(8):1415-20. PubMed ID: 7700845
    [Abstract] [Full Text] [Related]

  • 13. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
    Dumoulin V, Dakka T, Plaisancie P, Chayvialle JA, Cuber JC.
    Endocrinology; 1995 Nov 19; 136(11):5182-8. PubMed ID: 7588257
    [Abstract] [Full Text] [Related]

  • 14. Oxyntomodulin inhibits pancreatic secretion through the nervous system in rats.
    Anini Y, Jarrousse C, Chariot J, Nagain C, Yanaihara N, Sasaki K, Bernad N, Le Nguyen D, Bataille D, Rozé C.
    Pancreas; 2000 May 19; 20(4):348-60. PubMed ID: 10824688
    [Abstract] [Full Text] [Related]

  • 15. Effects of various gastrointestinal peptides on parietal cells and endocrine cells in the oxyntic mucosa of rat stomach.
    El Munshid HA, Håkanson R, Liedberg G, Sundler F.
    J Physiol; 1980 Aug 19; 305():249-65. PubMed ID: 6108365
    [Abstract] [Full Text] [Related]

  • 16. Glucagon-like peptide-1 7-36 amide and peptide YY have additive inhibitory effect on gastric acid secretion in man.
    Wettergren A, Maina P, Boesby S, Holst JJ.
    Scand J Gastroenterol; 1997 Jun 19; 32(6):552-5. PubMed ID: 9200286
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of gastric acid secretion by peptide YY is independent of gastric somatostatin release in the rat.
    Greeley GH, Guo YS, Gomez G, Lluis F, Singh P, Thompson JC.
    Proc Soc Exp Biol Med; 1988 Dec 19; 189(3):325-8. PubMed ID: 2905061
    [Abstract] [Full Text] [Related]

  • 18. Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): a potent inhibitor of pentagastrin-stimulated acid secretion in rats.
    Dubrasquet M, Bataille D, Gespach C.
    Biosci Rep; 1982 Jun 19; 2(6):391-5. PubMed ID: 6125221
    [No Abstract] [Full Text] [Related]

  • 19. Enterogastrone-like effect of peptide YY is vagally mediated in the dog.
    Pappas TN, Debas HT, Taylor IL.
    J Clin Invest; 1986 Jan 19; 77(1):49-53. PubMed ID: 2868024
    [Abstract] [Full Text] [Related]

  • 20. Effect of peptide YY on gastric motor and secretory activity in vagally innervated and denervated corpus pouch dogs.
    Zai H, Haga N, Fujino MA, Itoh Z.
    Regul Pept; 1996 Mar 22; 61(3):181-8. PubMed ID: 8701034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.